P11187

Piramal Enterprises Limited · Phase 1 active Small molecule

At a glance

Generic name	P11187
Also known as	Oral G-Protein Coupled Receptor 40(GPR40)agonist
Sponsor	Piramal Enterprises Limited
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187 (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

P11187 CI brief — competitive landscape report
P11187 updates RSS · CI watch RSS
Piramal Enterprises Limited portfolio CI